Biocon's Pertuzumab: A Milestone Biosimilar Approved for HER2-Positive Breast Cancer #India #Bengaluru #Biocon #HER2-positive #Pertuzumab

Biocon Achieves Positive CHMP Opinion for Pertuzumab Biosimilar, A First Under EMA’s New Clinical Approach #India #Bengaluru #Biocon #Biosimilar #Pertuzumab

Biocon's Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA's New Development Approach #India #Bengaluru #Biocon #Biosimilar #Pertuzumab

Biocon's Pertuzumab Biosimilar Receives Positive CHMP Opinion: A Major Milestone in Cancer Treatment #India #Bengaluru #Biocon #Pertuzumab #Pebrilzo